Argininosuccinate synthetase 1 depletion produces a metabolic state conducive to herpes simplex virus 1 infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 51, 2013, Pages

  Grady, Sarah L ^a   Purdy, John G ^a   Rabinowitz, Joshua D ^a   Shenk, Thomas ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

Herpesviruses; Metabolomics

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; ACYLTRANSFERASE; ARGININE DECARBOXYLASE; ARGININOSUCCINATE SYNTHASE; ARGININOSUCCINATE SYNTHETASE 1; ARGININOSUCCINIC ACID; ASPARTATE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE ISOENZYME 2; ASPARTIC ACID; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE II; ENZYME PRECURSOR; FK 506 BINDING PROTEIN; GLUTAMATE DECARBOXYLASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; HEPARAN SULFATE; METHIONINE TRANSFER RNA; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; NUCLEOTIDE; PUL30 PROTEIN; PYRUVATE CARBOXYLASE; SMALL INTERFERING RNA; SULFOTRANSFERASE; SYNAPTOTAGMIN; SYNTAXIN; SYNTAXIN 10; SYNTAXIN 19; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; XRCC4 PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME METABOLISM; FIBROBLAST; GENE IDENTIFICATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 1 INFECTION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PRECURSOR; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 84890833382     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1321305110     Document Type: Article

References (49)

1. Vastag L, Koyuncu E, Grady SL, Shenk TE, Rabinowitz JD (2011) Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog 7(7):e1002124.
2. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD (2006) Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog 2(12):e132.
3. Munger J, et al. (2008) Systems-Level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26(10):1179-1186.
4. Grady SL, Hwang J, Vastag L, Rabinowitz JD, Shenk T (2012) Herpes simplex virus 1 infection activates poly(ADP-Ribose) polymerase and triggers the degradation of poly (ADP-Ribose) glycohydrolase. J Virol 86(15):8259-8268.
5. Rabinowitz JD, Purdy JG, Vastag L, Shenk T, Koyuncu E (2011) Metabolomics in drug target discovery. Cold Spring Harb Symp Quant Biol 76:235-246.
6. Yu Y, Maguire TG, Alwine JC (2012) Human cytomegalovirus infection induces adipocyte-Like lipogenesis through activation of sterol regulatory element binding protein J Virol 86(6):2942-2949.
7. Koyuncu E, Purdy JG, Rabinowitz JD, Shenk T (2013) Saturated very long chain fatty acids are required for the production of infectious human cytomegalovirus progeny. PLoS Pathog 9(5):e1003333.
8. Munshi SU, et al. (2011) Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism. J Viral Hepat 18(10):e591-E602.
9. Birungi G, Chen SM, Loy BP, Ng ML, Li SF (2010) Metabolomics approach for investigation of effects of dengue virus infection using the EA.hy926 cell line. J Proteome Res 9(12):6523-6534.
10. Diamond DL, et al. (2010) Temporal proteome and lipidome profiles reveal hepatitis C virus-Associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog 6(1):e1000719.
11. Roe B, Kensicki E, Mohney R, HallWW(2011) Metabolomic profile of hepatitis C virusinfected hepatocytes. PLoS ONE 6(8):e23641.
12. Boehmer PE, Lehman IR (1997) Herpes simplex virus DNA replication. Annu Rev Biochem 66:347-384.
13. Ratner S (1982) Argininosuccinate synthetase of bovine liver: Chemical and physical properties. Proc Natl Acad Sci USA 79(17):5197-5199.
14. Kobayashi K, Jackson MJ, Tick DB, O'Brien WE, Beaudet AL (1990) Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. J Biol Chem 265(19):11361-11367.
15. Xie L, Gross SS (1997) Argininosuccinate synthetase overexpression in vascular smooth muscle cells potentiates immunostimulant-Induced NO production. J Biol Chem 272(26):16624-16630.
16. Zhang YQ, Lai W, Li H, Li G (2008) Inhibition of herpes simplex virus type 1 by small interfering RNA. Clin Exp Dermatol 33(1):56-61.
17. Muylaert I, Elias P (2007) Knockdown of DNA ligase IV/XRCC4 by RNA interference inhibits herpes simplex virus type I DNA replication. J Biol Chem 282(15):10865-10872.
18. Birmingham A, et al. (2009) Statistical methods for analysis of high-Throughput RNA interference screens. Nat Methods 6(8):569-575.
19. O'Donnell CD, Kovacs M, Akhtar J, Valyi-Nagy T, Shukla D (2010) Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry. Virology 397(2): 389-398.
20. Boehmer PE (1996) Expression, purification, and characterization of the herpes simplex virus type-1 DNA polymerase. Methods Enzymol 275:16-35.
21. Fields BN, Knipe DM, Howley PM (2007) Fields Virology (Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia) 5th Ed.
22. Honess RW, Roizman B (1974) Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 14(1): 8-19.
23. Tankersley RW, Jr. (1964) Amino acid requirements of herpes simplex virus in human cells. J Bacteriol 87:609-613.
24. Roizman B, Spring SB, Roane PR, Jr. (1967) Cellular compartmentalization of herpesvirus antigens during viral replication. J Virol 1(1):181-192.
25. Seyffarth G, et al. (2004) Lipopolysaccharide induces nitric oxide synthase expression and platelet-Activating factor increases nitric oxide production in human fetal membranes in culture. Reprod Biol Endocrinol 2:29.
26. Wang R, Ghahary A, Shen YJ, Scott PG, Tredget EE (1996) Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 106(3):419-427.
27. Mehta DR, Ashkar AA, Mossman KL (2012) The nitric oxide pathway provides innate antiviral protection in conjunction with the type I interferon pathway in fibroblasts. PLoS ONE 7(2):e31688.
28. Regev-Shoshani G, et al. (2013) Gaseous nitric oxide reduces influenza infectivity in vitro. Nitric Oxide 31:48-53.
29. Bi Z, Reiss CS (1995) Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol 69(4):2208-2213.
30. Croen KD (1993) Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 91(6):2446-2452.
31. Hart CM, Kleinhenz DJ, Dikalov SI, Boulden BM, Dudley SC, Jr. (2005) The measurement of nitric oxide production by cultured endothelial cells. Methods Enzymol 396:502-514.
32. Gibson W, Roizman B (1971) Compartmentalization of spermine and spermidine in the herpes simplex virion. Proc Natl Acad Sci USA 68(11):2818-2821.
33. Roizman B, et al. (1975) Human herpersviruses I: A model for molecular organization and regulation of herpesviruses-A review. IARC Sci Publ (11 Pt 1):3-38.
34. Spencer CA, Dahmus ME, Rice SA (1997) Repression of host RNA polymerase II transcription by herpes simplex virus typee J Virol 71(3):2031-2040.
35. Fraser KA, Rice SA (2007) Herpes simplex virus immediate-Early protein ICP22 triggers loss of serine 2-Phosphorylated RNA polymerase II. J Virol 81(10):5091-5101.
36. Hardy WR, Sandri-Goldin RM (1994) Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J Virol 68(12):7790-7799.
37. Caradonna SJ, Cheng YC (1981) Induction of uracil-DNA glycosylase and dUTP nucleotidohydrolase activity in herpes simplex virus-Infected human cells. J Biol Chem 256(19):9834-9837.
38. McMurray WC (1962) Biochemical genetics and mental retardation. Can Med Assoc J 87(9):486-490.
39. Beaudet AL, O'Brien WE, Bock HG, Freytag SO, Su TS (1986) The human argininosuccinate synthetase locus and citrullinemia. Adv Hum Genet 15:161-196, 291-292.
40. Engel K, Höhne W, Häberle J (2009) Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene. Hum Mutat 30(3):300-307.
41. Ye X, Whiteman B, Jerebtsova M, Batshaw ML (2000) Correction of argininosuccinate synthetase (AS) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human AS cDNA. Gene Ther 7(20):1777-1782.
42. Lee B, et al. (1999) Hepatocyte gene therapy in a large animal: A neonatal bovine model of citrullinemia. Proc Natl Acad Sci USA 96(7):3981-3986.
43. Patejunas G, et al. (1998) Evaluation of gene therapy for citrullinaemia using murine and bovine models. J Inherit Metab Dis 21(Suppl 1):138-150.
44. Ejercito PM, Kieff ED, Roizman B (1968) Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 2(3): 357-364.
45. Yu D, Smith GA, Enquist LW, Shenk T (2002) Construction of a self-Excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J Virol 76(5):2316-2328.
46. Boutros M, Brás LP, Huber W (2006) Analysis of cell-Based RNAi screens. Genome Biol 7(7):R66.
47. Browne EP, Wing B, Coleman D, Shenk T (2001) Altered cellular mRNA levels in human cytomegalovirus-Infected fibroblasts: Viral block to the accumulation of antiviral mRNAs. J Virol 75(24):12319-12330.
48. Melamud E, Vastag L, Rabinowitz JD (2010) Metabolomic analysis and visualization engine for LC-MS data. Anal Chem 82(23):9818-9826.
49. Bogani F, et al. (2010) Association between the herpes simplex virus-1 DNA polymerase and uracil DNA glycosylase. J Biol Chem 285(36):27664-27672.